Find a Drug
Advanced Search

Hepatitis C

font size


Hepatitis C

Medical Author: Tse-Ling Fong, M.D.
Medical Editor: Leslie J. Schoenfield, M.D., Ph.D.

What is the scope of the hepatitis C problem?

The hepatitis C virus (HCV) is one of the most significant health problems affecting the liver. More than 4 million Americans (1.3% of the U.S. population) and 170 million individuals in the world (3% worldwide) are infected with hepatitis C virus. The prevalence (number of cases in a population at a specific time) of hepatitis C virus infections varies in different parts of the world. For example, the prevalence of hepatitis C virus in Scandinavia is less than 0.5% of the population, whereas the prevalence in Egypt is over 20%. In the U.S. and Western Europe, the complications of hepatitis C virus chronic hepatitis and cirrhosis are the most common reasons for liver transplantation.

One of the major problems with hepatitis C virus infections is that 85% of individuals initially infected with this virus will become chronically infected, usually for decades. The other 15% of hepatitis C virus infected individuals simply have an acute infection; that is, one that resolves spontaneously in a few weeks or months. The propensity of hepatitis C virus to cause chronic infection is explained by the extraordinary ability of this virus (in contrast to most other viruses, including hepatitis A) to avoid destruction by the body's immune defense system. (The immune system includes antibodies and specialized white blood cells, called lymphocytes).

Once established, chronic hepatitis C virus infection causes an inflammation of the liver called chronic hepatitis. This condition can progress to scarring of the liver, called fibrosis, or more advanced scarring, called cirrhosis. Some patients with cirrhosis will go on to develop liver failure or the complications of cirrhosis, including liver cancer.

In the U.S., the number of new cases of hepatitis C has declined over the last 10 years from a peak of some 200,000 annually to about 28,000 in 1999. This striking reduction is the result of a drop in the number of cases of acute hepatitis C among intravenous drug users. Perhaps this decrease among the drug users is due to changes in their practices brought on by their awareness of HIV infection. Furthermore, sensitive blood tests for the detection of hepatitis C virus became available to screen the blood supply and individuals at high risk for hepatitis C virus.

Indeed, with blood being routinely screened for hepatitis C virus, the risk of a single unit of blood transmitting hepatitis C today is less than 1 in 100,000. Still, because of the many individuals who became infected 10 to 20 years ago, the number of deaths (or the need for liver transplantation) due to the complications of chronic hepatitis C virus liver disease is expected to triple within the next decade or two. On the other hand, in recent years, our understanding of the hepatitis C virus and its management has increased substantially.



Next: What is the nature (biology) of the hepatitis C virus (HCV)? »

Last Editorial Review: 9/17/2005

Source: MedicineNet.com
http://www.medicinenet.com/hepatitis_c/article.htm

WebMD Symptom Checker - Start Here Diseases & Conditions: A comprehensive A-Z listing

Hepatitis C Treatment Hepatitis C Treatment
Millions of Americans live with Hepatitis C and many don’t even know it. Early detection along with a new treatment is making an impact. See more WebMD Videos »

WebMD Daily

Get breaking medical news.